Program preview · clinical & pricing approval pending
12-month agreement. One-time enrollment is separate. Treatment eligibility and program selection require clinical review. Online enrollment and payment are not available.
A conversation worth having
When Bladder Leaks Interrupt Everyday Life.
A leak when you laugh or exercise isn’t always the same as a sudden urge to go.
Understanding when and how your symptoms happen helps your LPWWC clinical team discuss the care options that may be right for you.
Coughing or Sneezing
Leakage when you cough, laugh, or sneeze may be a sign of stress urinary incontinence.
Exercise & Movement
Experiencing leakage during running, lifting, or everyday activity? It’s worth discussing what may be contributing.
Urgency or Mixed Symptoms
A sudden need to go, sometimes combined with other types of leakage, may require a different approach.
Pelvic Floor Concerns
Pelvic floor strength and coordination can affect bladder control, but other factors may also contribute.
Not Sure Where to Start?
You don’t need to know the cause of your symptoms. A conversation with our team is a good first step.
Different symptoms may require different care. Your clinical evaluation helps determine whether either LPWWC program is appropriate.
Two programs. One personalized approach.
Explore Two Programs. Know What’s Included.
Two physician-directed approaches to bladder and pelvic health, with clear treatment plans and predictable monthly payments.
Compare what’s included, understand the cost, and explore which option may be appropriate for you.
Starting at $99/monthSeparate one-time enrollment payment. Twelve monthly payments.
Your clinical evaluation determines which treatment approach, if any, is appropriate.
Program preview · clinical & pricing approval pending.
Nine modality treatments; some can share a visit. Clinical eligibility and final schedule require review.
1 of 2
Both programs require a separate enrollment payment and twelve monthly payments. Treatment schedules and payment schedules are separate.
Annual payment agreements—not freely cancelable month-to-month plans. Final pricing and terms await LPWWC approval; online enrollment and payment are not available.
How Billing and Treatment Scheduling Work
Monthly payments are proposed to begin 30 days after enrollment.
The initial treatment series may be completed before all twelve monthly payments have been made.
These are annual payment agreements, not month-to-month plans that can be canceled at any time.
Program selection and clinical eligibility require evaluation. Final pricing, enrollment, cancellation, and treatment terms remain subject to LPWWC approval.
See the Difference in Dollars.
Compare the monthly payments or see the complete first-year cost, including enrollment.
Bladder Control$99
Bladder + Pelvic Restore$179
$80 more per month for the combined program.
What’s different?
What Does Pelvic Restore Add?
Both programs include 6 vTone treatments. The combined program adds 3 FormaV treatments when the physician determines that additional tissue-directed care is appropriate.
Additional investment$80 more per monthPlus $300 additional enrollment.$1,260 difference in total first-year cost.
The combined program is considered when additional treatment may be appropriate following clinical evaluation. It is not an automatic upgrade, and individual outcomes vary.
Your care journey
Your Care. A Clear Path Forward.
Every journey begins with understanding your symptoms.
If treatment is appropriate, we’ll help you understand your program, plan your initial sessions, and review your progress before deciding what comes next.
01
Explore Your Options
Compare our two proposed programs, see what’s included, and understand the enrollment and monthly costs.
02
Your Clinical Evaluation
Meet with our clinical team to discuss your symptoms, medical history, and which treatment approach may be appropriate.
03
Begin Your Treatment Plan
Your proposed initial program includes six vTone treatments, generally scheduled weekly. The combined program adds three FormaV treatments at selected visits when appropriate.
04
Review Your Progress
Following the initial treatment series, your clinician reviews your response, symptoms, and any remaining concerns.
05
Decide What’s Next
Depending on your response, discuss follow-up care, further evaluation, or additional treatment options when appropriate.
Understanding your treatment options
Two Technologies. Different Approaches to Care.
Not all bladder and pelvic health concerns are the same, and neither are the technologies used in treatment.
Here’s how vTone and FormaV differ and where they fit within our two proposed programs.
Included in Program 1 & Program 2
Pelvic floor muscle stimulation
vTone
vTone uses controlled electrical stimulation through an intravaginal applicator to activate pelvic floor muscles.
It is the foundational technology in both proposed LPWWC programs.
Clinical Considerations: vTone
Your clinical team determines whether this treatment is appropriate based on your symptoms, medical history, and individual needs.
Electrical stimulation is distinct from radiofrequency treatment. Individual suitability requires clinical evaluation.
Program 2 Only
Radiofrequency tissue treatment
FormaV
FormaV uses controlled radiofrequency energy to warm vaginal and vulvar tissues.
Unlike vTone, which stimulates pelvic floor muscles, FormaV is a tissue-directed treatment.
Clinical Considerations: FormaV
It is included in the proposed combined program only when your physician determines that additional treatment is appropriate.
It is not a substitute for other indicated pelvic-floor or gynecologic care. These technologies are not interchangeable and do not share identical device indications.
Device images are illustrative artwork, not manufacturer photographs. Published studies use different populations and protocols; they do not guarantee results or validate this proposed program for every patient.
Explore the Research Behind These Technologies
Learn what published research has examined, what the findings suggest, and where important questions remain.
Clinical Research & References
Electrical-stimulation research and combined radiofrequency research are not interchangeable. The proposed six vTone + three FormaV schedule is not the same regimen as the prospective combined-treatment study.
Studied women unable to contract their pelvic-floor muscles voluntarily, using weekly electrical stimulation over eight weeks. It did not test radiofrequency or LPWWC’s proposed regimen.
Reviews electrical-stimulation trials with differing methods. It does not establish one universal treatment schedule or evidence specific to the combined program.
Compares nonimplantable electrical-stimulation approaches. Electrical stimulation and radiofrequency are different technologies; evidence for one cannot simply be applied to the other.
Used three RF and electrical-stimulation treatments two weeks apart, together with education and pelvic-floor rehabilitation. It cannot isolate each component’s contribution. LPWWC’s proposed six vTone plus three FormaV program is an adaptation, not the identical published protocol.
The record classifies this as a nonimplantable electrical continence device. A 510(k) substantial-equivalence decision is not FDA approval or a promise of patient results; device intended use and individual suitability still require clinical review.
Personalized additional care
Additional Options, When They’re Right for You.
Optional Additional Treatment
Sometimes, a clinical evaluation or follow-up identifies a need to discuss treatment beyond the initial program.
If appropriate, your physician may recommend a separate tissue-directed treatment.
Morpheus8V
Morpheus8V uses fractional radiofrequency microneedling for tissue-directed treatment.
It is not included in either bladder control program and is considered separately when clinically appropriate.
Your physician will discuss whether it’s suitable for you, what treatment may involve, and any additional cost before proceeding.
Any treatment count, interval and separate quote require clinical review. Not a third membership or a required upgrade.
After your initial treatment series, your clinician will review your progress and help determine whether follow-up, additional evaluation, or further care may be appropriate.
01
Meaningful Improvement
If your symptoms have improved, discuss your progress, follow-up needs, and whether any maintenance care makes sense.
02
Some Improvement
If you’ve noticed some change but still have concerns, your clinician can reassess your response and discuss appropriate next steps.
03
Little or No Improvement
If treatment hasn’t helped as expected, your clinician can revisit possible causes, consider other options, and determine whether additional evaluation is needed.
Your next step is based on your individual response, not an automatic schedule of additional procedures.
Your pelvic health library
A Little Clarity Goes a Long Way.
Explore six free draft guides covering bladder health, pelvic floor function, treatment options, and what to expect before and after care.
Read online at your own pace, or request a downloadable copy to keep.
Complete draft collection · clinical and operational approval pending.
Guide 01
Why Bladder Leaks Happen
Recognize different symptom patterns, understand evaluation and explore established care options.
Proposed program details are educational. Final clinical protocols, pricing and agreement terms require approval.
What is the difference between the two programs?
Bladder Control proposes vTone pelvic-floor electrical stimulation. Bladder + Pelvic Restore adds FormaV radiofrequency treatment when the physician considers tissue-directed treatment appropriate. Your symptoms do not automatically determine which program is suitable.
How many initial treatments are included?
Bladder Control proposes 6 vTone treatments. Bladder + Pelvic Restore proposes 6 vTone plus 3 FormaV treatments. These are nine modality treatments, not necessarily nine separate appointments; some may share a visit. Final inclusions require clinical approval.
Is the treatment schedule weekly?
The proposed initial vTone schedule is once weekly over six weeks. For the combined program, FormaV is proposed at Weeks 1, 3 and 5. These are draft schedules, not a universal protocol; the clinical team must approve your actual plan.
How much is enrollment, and what will I pay monthly?
Proposed Bladder Control pricing is $499 enrollment plus $99 per month for 12 months. Proposed Bladder + Pelvic Restore pricing is $799 enrollment plus $179 per month for 12 months. Enrollment is separate; monthly payments are proposed to begin 30 days after enrollment. Final prices and agreement terms await approval; online purchase is unavailable.
What is my total first-year program cost?
The proposed first-year totals are $1,687 for Bladder Control and $2,947 for Bladder + Pelvic Restore. Each total includes one-time enrollment plus twelve monthly payments. Optional separately quoted care is not included.
Why does the payment agreement run 12 months if treatments happen earlier?
The proposed agreement pays for a defined annual program through separate enrollment and twelve fixed monthly payments. Initial treatment can finish before those payments do. It is not a monthly treatment entitlement or a freely cancelable month-to-month plan. Final written terms must be approved before enrollment.
Is MorpheusV included?
No. MorpheusV / Morpheus8V is an optional physician-selected treatment, not a third standard program or an automatic inclusion. Any recommendation, treatment schedule and separate quote require clinical review.
What happens after the first treatment phase?
After your initial treatment series, your LPWWC clinician will review how you’ve responded and whether any symptoms remain. Some patients may only need appropriate follow-up. Others may benefit from further evaluation or a discussion about additional treatment. Any future care, including maintenance or optional procedures, is considered separately based on your needs and the clinician’s recommendations. There is no automatic requirement to continue treatment simply because the initial program has ended.
Is everyone a candidate?
No. Urinary leakage and pelvic-floor symptoms can have different causes. A clinical evaluation is necessary to decide whether these treatments, another form of care, or further investigation is appropriate. This page does not establish eligibility.
What if my symptoms do not improve enough?
Discuss your response with the clinician. Partial response may prompt a discussion of limited additional treatment and reevaluation. Minimal response calls for clinical reassessment rather than an assumption that more device sessions are the answer. Results are not guaranteed.
Are ongoing maintenance options available?
A possible follow-up or maintenance model is under clinical review. No maintenance treatment count, price or automatic renewal is confirmed here. The team must approve and explain any future offer before you agree to it.
How do I get started?
Answer the preliminary questionnaire on this page to see whether further evaluation may be worth exploring. It is a draft pending clinical approval: it does not diagnose, confirm eligibility, schedule care or accept payment, and your answers are not saved. Whatever your result, enrollment and payment remain unavailable online — contact the clinic or call (307) 745-8991 to discuss next steps.
Bladder control & pelvic restoration
A Thoughtful Starting Point.
Explore the two proposed programs. Then talk with the clinic about what is appropriate for you.
